KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Inventory (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Change in Inventory for 14 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 231.16% to $4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2025, up 147.46% year-over-year, with the annual reading at $7.5 million for FY2025, 147.46% up from the prior year.
  • Change in Inventory for Q4 2025 was $4.2 million at Supernus Pharmaceuticals, down from $12.9 million in the prior quarter.
  • The five-year high for Change in Inventory was $12.9 million in Q3 2025, with the low at -$6.9 million in Q3 2023.
  • Average Change in Inventory over 5 years is $901200.0, with a median of $1.2 million recorded in 2021.
  • The sharpest move saw Change in Inventory soared 2606.67% in 2021, then plummeted 251.42% in 2024.
  • Over 5 years, Change in Inventory stood at $5.2 million in 2021, then soared by 120.12% to $11.6 million in 2022, then tumbled by 143.52% to -$5.0 million in 2023, then surged by 36.61% to -$3.2 million in 2024, then soared by 231.16% to $4.2 million in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $4.2 million, $12.9 million, and -$4.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.